|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Salem A, Asselin MC, Reymen B, Jackson A,
Lambin P, West CML, O'Connor JPB and Faivre-Finn C: Targeting
hypoxia to improve non-small cell lung cancer outcome. J Natl
Cancer Inst. 110:2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lin DD, Shen Y, Qiao S, Liu WW, Zheng L,
Wang YN, Cui N, Wang YF, Zhao S and Shi JH: Upregulation of OTUD7B
(Cezanne) promotes tumor progression via AKT/VEGF pathway in lung
squamous carcinoma and adenocarcinoma. Front Oncol. 9:8622019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang J, Lu Q, Cai J, Wang Y, Lai X, Qiu Y,
Huang Y, Ke Q, Zhang Y, Guan Y, et al: Nestin regulates cellular
redox homeostasis in lung cancer through the Keap1-Nrf2 feedback
loop. Nat Commun. 10:50432019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang N, Guo W, Ren K, Li W, Jiang Y, Sun
J, Dai W and Zhao W: LncRNA AFAP1-AS1 supresses miR-139-5p and
promotes cell proliferation and chemotherapy resistance of
non-small cell lung cancer by competitively upregulating RRM2.
Front Oncol. 9:11032019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pfannschmidt J, Muley T, Bulzebruck H,
Hoffmann H and Dienemann H: Prognostic assessment after surgical
resection for non-small cell lung cancer: Experiences in 2083
patients. Lung Cancer. 55:371–377. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reungwetwattana T, Weroha SJ and Molina
JR: Oncogenic pathways, molecularly targeted therapies, and
highlighted clinical trials in non-small-cell lung cancer (NSCLC).
Clin Lung Cancer. 13:252–266. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Karuppasamy R, Veerappapillai S, Maiti S,
Shin WH and Kihara D: Current progress and future perspectives of
polypharmacology: From the view of non-small cell lung cancer.
Semin Cancer Biol. Nov 4–2019.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hirashima T, Satouchi M, Hida T, Nishio M,
Kato T, Sakai H, Imamura F, Kiura K, Okamoto I, Kasahara K, et al:
Osimertinib for Japanese patients with T790M-positive advanced
non-small-cell lung cancer: A pooled subgroup analysis. Cancer Sci.
110:2884–2893. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Balekian AA, Wisnivesky JP and Gould MK:
Surgical disparities among patients with stage i lung cancer in the
national lung screening trial. Chest. 155:44–52. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Davis JN, Medbery C, Sharma S, Pablo J,
Kimsey F, Perry D, Muacevic A and Mahadevan A: Stereotactic body
radiotherapy for centrally located early-stage non-small cell lung
cancer or lung metastases from the RSSearch(®) patient
registry. Radiat Oncol. 10:1132015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
ENCODE Project Consortium: An integrated
encyclopedia of DNA elements in the human genome. Nature.
489:57–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shaughnessy AF: High false-positive rate
with lung cancer screening. Am Fam Physician. 96:128–129.
2017.PubMed/NCBI
|
|
15
|
Belanger AR and Akulian JA: An update on
the role of advanced diagnostic bronchoscopy in the evaluation and
staging of lung cancer. Ther Adv Respir Dis. 11:211–221. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiang M, Huang O, Xie Z, Wu S, Zhang X,
Shen A, Liu H, Chen X, Wu J, Lou Y, et al: A novel long non-coding
RNA-ARA: Adriamycin resistance-associated. Biochem Pharmacol.
87:254–283. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yan B and Wang Z: Long noncoding RNA: Its
physiological and pathological roles. DNA Cell Biol. 31 (Suppl
1):S34–S41. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fang XY, Pan HF, Leng RX and Ye DQ: Long
noncoding RNAs: Novel insights into gastric cancer. Cancer Lett.
356:357–366. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kaikkonen MU, Lam MT and Glass CK:
Non-coding RNAs as regulators of gene expression and epigenetics.
Cardiovasc Res. 90:430–440. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li X, Wu Z, Fu X and Han W: Long noncoding
RNAs: Insights from biological features and functions to diseases.
Med Res Rev. 33:517–553. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guttman M and Rinn JL: Modular regulatory
principles of large non-coding RNAs. Nature. 482:339–346. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Martianov I, Ramadass A, Serra Barros A,
Chow N and Akoulitchev A: Repression of the human dihydrofolate
reductase gene by a non-coding interfering transcript. Nature.
445:666–670. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gong Z, Zhang S, Zhang W, Huang H, Li Q,
Deng H, Ma J, Zhou M, Xiang J, Wu M, et al: Long non-coding RNAs in
cancer. Sci China Life Sci. 55:1120–1124. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu W, Gius D, Onyango P, Muldoon-Jacobs K,
Karp J, Feinberg AP and Cui H: Epigenetic silencing of tumour
suppressor gene p15 by its antisense RNA. Nature. 451:202–206.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hung T and Chang HY: Long noncoding RNA in
genome regulation: Prospects and mechanisms. RNA Biol. 7:582–585.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Satish S, Sourav G, Vaibhav J, Vinod S and
Shantanu S: Genome-wide analysis reveals distinct patterns of
epigenetic features in long non-coding RNA loci. Nucleic Acids Res.
40:10018–10031. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Volders PJ, Helsens K, Wang X, Menten B,
Martens L, Gevaert K, Vandesompele J and Mestdagh P: LNCipedia: A
database for annotated human lncRNA transcript sequences and
structures. Nucleic Acids Res. 41((Database Issue)): D246–D251.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Niazi F and Valadkhan S: Computational
analysis of functional long noncoding RNAs reveals lack of
peptide-coding capacity and parallels with 3′ UTRs. RNA.
18:825–843. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Moran VA, Perera RJ and Khalil AM:
Emerging functional and mechanistic paradigms of mammalian long
non-coding RNAs. Nucleic Acids Res. 40:6391–6400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Brunner AL, Beck AH, Edris B, Sweeney RT,
Zhu SX, Li R, Montgomery K, Varma S, Gilks T, Guo X, et al:
Transcriptional profiling of long non-coding RNAs and novel
transcribed regions across a diverse panel of archived human
cancers. Genome Biol. 13:R752012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Seroussi E, Kedra D, Pan HQ, Peyrard M,
Schwartz C, Scambler P, Donnai D, Roe BA and Dumanski JP:
Duplications on human chromosome 22 reveal a novel Ret Finger
Protein-like gene family with sense and endogenous antisense
transcripts. Genome Res. 9:803–814. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Travis WD, Brambilla E, Nicholson AG,
Yatabe Y, Austin JHM, Beasley MB, Chirieac LR, Dacic S, Duhig E,
Flieder DB, et al: The 2015 world health organization
classification of lung tumors: Impact of Genetic, Clinical and
radiologic advances since the 2004 classification. J Thorac Oncol.
10:1243–1260. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Anna W and Jacek J: The new TNM
classification in lung cancer. Pneumonol Alergol Pol. 78:407–417.
2010.(In Polish). PubMed/NCBI
|
|
36
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lin HY, Zeng, Liang YK, Wei XL and Chen
CF: GATA3 and TRPS1 are distinct biomarkers and prognostic factors
in breast cancer: Database mining for GATA family members in
malignancies. Oncotarget. 8:34750–34761. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pao W, Miller VA, Politi KA, Riely GJ,
Somwar R, Zakowski MF, Kris MG and Varmus H: Acquired resistance of
lung adenocarcinomas to gefitinib or erlotinib is associated with a
second mutation in the EGFR kinase domain. PLoS Med. 2:e732005.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Engelman JA, Zejnullahu K, Mitsudomi T,
Song Y, Hyland C, Park JO, Lindeman N, Gale CM, Zhao X, Christensen
J, et al: MET amplification leads to gefitinib resistance in lung
cancer by activating ERBB3 signaling. Science. 316:1039–1043. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Choi YL, Soda M, Yamashita Y, Ueno T,
Takashima J, Nakajima T, Yatabe Y, Takeuchi K, Hamada T, Haruta H,
et al: EML4-ALK mutations in lung cancer that confer resistance to
ALK inhibitors. N Engl J Med. 363:1734–1739. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mittal V: Epithelial mesenchymal
transition in aggressive lung cancers. Adv Exp Med Biol. 890:37–56.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J
and Fang G: Up-regulated long non-coding RNA H19 contributes to
proliferation of gastric cancer cells. FEBS J. 279:3159–3165. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Qi D, Li J, Que B, Su J, Li M, Zhang C,
Yang M, Zhou G and Ji W: Long non-coding RNA DBCCR1-003 regulate
the expression of DBCCR1 via DNMT1 in bladder cancer. Cancer Cell
Int. 16:812016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Qiu MT, Hu JW, Yin R and Xu L: Long
noncoding RNA: An emerging paradigm of cancer research. Tumour
Biol. 34:613–620. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sun J, Song Y, Chen X, Zhao J, Gao P,
Huang X, Xu H and Wang Z: Novel long non-coding RNA RP11-119F7.4 as
a potential biomarker for the development and progression of
gastric cancer. Oncol Lett. 10:115–120. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tian Y, Zheng Y and Dong X: AGAP2-AS1
serves as an oncogenic lncRNA and prognostic biomarker in
glioblastoma multiforme. J Cell Biochem. 120:9056–9062. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kunej T, Obsteter J, Pogacar Z, Horvat S
and Calin GA: The decalog of long non-coding RNA involvement in
cancer diagnosis and monitoring. Crit Rev Clin Lab Sci. 51:344–357.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang S, Ma H, Zhang D, Xie S, Wang W, Li
Q, Lin Z and Wang Y: LncRNA KCNQ1OT1 regulates proliferation and
cisplatin resistance in tongue cancer via miR-211-5p mediated
Ezrin/Fak/Src signaling. Cell Death Dis. 9:7422018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lu Z, Xiao Z, Liu F, Cui M, Li W, Yang Z,
Li J, Ye L and Zhang X: Long non-coding RNA HULC promotes tumor
angiogenesis in liver cancer by up-regulating sphingosine kinase 1
(SPHK1). Oncotarget. 7:241–254. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Liang H, Tong Y, Yue H, Jiang H, Wang C,
You T, Zhao X, Shan H, Yang R, Yang L, et al: LncRNA PTAR promotes
EMT and invasion-metastasis in serous ovarian cancer by
competitively binding miR-101-3p to regulate ZEB1 expression. Mol
Cancer. 17:1192018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Su M, Xiao Y, Ma J, Cao D, Zhou Y, Wang H,
Liao Q and Wang W: Long non-coding RNAs in esophageal cancer:
Molecular mechanisms, functions, and potential applications. J
Hematol Oncol. 11:1182018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Barletta JA, Yeap BY and Chirieac LR:
Prognostic significance of grading in lung adenocarcinoma. Cancer.
116:659–669. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Tabata K, Tanaka T, Hayashi T, Hori T,
Nunomura S, Yonezawa S and Fukuoka J: Ki-67 is a strong prognostic
marker of non-small cell lung cancer when tissue heterogeneity is
considered. BMC Clin Pathol. 14:232014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Woodard GA, Jones KD and Jablons DM: Lung
cancer staging and prognosis. Cancer Treat Res. 170:47–75. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhang H and Cai B: The impact of tobacco
on lung health in China. Respirology. 8:17–21. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Levine AJ, Momand J and Finlay CA: The p53
tumour suppressor gene. Nature. 351:453–456. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Fujino M, Dosaka-Akita H, Harada M,
Hiroumi H, Kinoshita I, Akie K and Kawakami Y: Prognostic
significance of p53 and ras p21 expression in nonsmall cell lung
cancer. Cancer. 76:2457–2463. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Pfeifer GP, Denissenko MF, Olivier M,
Tretyakova N, Hecht SS and Hainaut P: Tobacco smoke carcinogens,
DNA damage and p53 mutations in smoking-associated cancers.
Oncogene. 21:7435–7451. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
The Medical Research Council: Tobacco
smoking and lung cancer. Br Med J. 1:1523–1524. 1957. View Article : Google Scholar
|
|
62
|
Chen W, Lu J, Qin Y, Wang J, Tian Y, Shi
D, Wang S, Xiao Y, Dai M, Liu L, et al: Ret finger protein-like 3
promotes tumor cell growth by activating telomerase reverse
transcriptase expression in human lung cancer cells. Oncotarget.
5:11909–11923. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Lin C, Qin Y, Zhang H, Gao MY and Wang YF:
EGF upregulates RFPL3 and hTERT via the MEK signaling pathway in
nonsmall cell lung cancer cells. Oncol Rep. 40:29–38.
2018.PubMed/NCBI
|
|
64
|
Yu Q, Wangbing C, Yao X, Yu W, Cai X, Dai
M, Xu T, Huang W, Guo W, Deng W and Wu T: RFPL3 and CBP
synergistically upregulate hTERT activity and promote lung cancer
growth. Oncotarget. 6:27130–27145. 2015. View Article : Google Scholar : PubMed/NCBI
|
